Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05198284 · ClinicalTrials.gov registry record
Prospective Decision Impact Clinical Utility Trial of KidneyIntelX
A clinical trial of Chronic Kidney Diseases and Diabetic Kidney Disease, sponsored by Renalytix AI.
- Active
- Registry status
- 2,000
- Enrollment target
- 1
- Study location
NCT05198284 is a study of Chronic Kidney Diseases and Diabetic Kidney Disease that is active but no longer recruiting, run by Renalytix AI. The registered enrollment target is 2,000 participants, above the 417-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (380% higher). The trial reports 1 study location across 1 state.
The verdict
NCT05198284, a study of Chronic Kidney Diseases and Diabetic Kidney Disease, is active but no longer recruiting, sponsored by Renalytix AI.
- ACTIVE NOT RECRUITING
- Registry status
- 2,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The clinical utility trial is designed to evaluate how the results of KidneyIntelX test / platform impacts on the clinical management of type 2 diabetes patients identified as increased risk for rapid kidney function decline within 5-years.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST KidneyIntelX
Study Locations (1)
New York
- Mount Sinai Health System - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,000 participants |
| Start Date | 2021-11-01 |
| Est. Completion | 2026-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05198284
The ClinicalTrials.gov registry entry for NCT05198284 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 2,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 417-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (380% higher). The listed sponsor is Renalytix AI, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which KidneyIntelX is the first listed.
NCT05198284 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05198284 about?
NCT05198284 is a clinical study titled "Prospective Decision Impact Clinical Utility Trial of KidneyIntelX". The clinical utility trial is designed to evaluate how the results of KidneyIntelX test / platform impacts on the clinical management of type 2 diabetes patients identified as increased risk for rapid kidney function decline within 5-years.
What is the current status of trial NCT05198284?
This trial is currently active not recruiting. The enrollment target is 2,000 participants. The study started on 2021-11-01. Estimated completion is 2026-11-01.
What conditions does trial NCT05198284 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases, Diabetic Kidney Disease, Chronic Kidney Disease Stage 3, Chronic Kidney Disease Stage 2, Chronic Kidney Disease Stage 1.
What interventions are being tested in trial NCT05198284?
The interventions under investigation include: KidneyIntelX (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05198284?
This trial is sponsored by Renalytix AI, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05198284 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
RECRUITING
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
RECRUITING · Phase 2
-
Mindfulness in Chronic Kidney Disease
RECRUITING · NA
-
Ferric Citrate and Chronic Kidney Disease in Children
RECRUITING · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.